Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DRM”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Very early researchStudy completedNCT04103333
What this trial is testing

Angelman Syndrome (AS) Biomarker Study

Who this might be right for
Angelman SyndromeChromosome 15q Duplication (dup15q) Syndrome
Biogen 20
Not applicableNot Yet RecruitingNCT06661317
What this trial is testing

Primary and Secondary Drug Resistance Mutations (DRMs) in HIV As a Risk Factor of Failure of ART, Including Two Drugs Based Regimens.

Who this might be right for
HIV-1-infectionDRMDRM Gene Mutation+1 more
Medical University of Warsaw 200
Not applicableStudy completedNCT06866366
What this trial is testing

Retrospective, Multicenter, Single-arm, Observational Study, With Data From Patients With T2DM With Malnutrition or at Risk, Who Were Prescribed Resource® Diabet Plus as a Hypercaloric and Hyperproteic Specific Formula for Patients With T2DM

Who this might be right for
Malnourished ElderlyMalnourishmentDiabetes Mellitus Type 2
Outcomes'10 59
Not applicableLooking for participantsNCT06353620
What this trial is testing

Structural-functional Connectome in Drug-resistant Epilepsies and Neurodevelopmental Syndromes With Epilepsy

Who this might be right for
EpilepsyAngelman SyndromeDup15q Syndrome
IRCCS Eugenio Medea 120
Testing effectiveness (Phase 2)Study completedNCT03694275
What this trial is testing

A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)

Who this might be right for
15q Duplication SyndromeCDKL5 Deficiency Disease
Takeda 20
Not applicableLooking for participantsNCT06342440
What this trial is testing

Early Detection of Advanced Adenomas and Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal NeoplasmsColorectal Polyp+15 more
City of Hope Medical Center 2,000
Very early researchUnknownNCT05281965
What this trial is testing

A Clinical Study Evaluating the Efficacy and Safety of Retinoic Acid in Patients With 15q11-q13 Duplication Syndrome

Who this might be right for
AutismTreatment AdherenceRetinoic Acid+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 20
Testing effectiveness (Phase 2)Ended earlyNCT05307679
What this trial is testing

Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome

Who this might be right for
Dup15q Syndrome
Hoffmann-La Roche 7
Not applicableEnrolling By InvitationNCT03836300
What this trial is testing

Parent and Infant Inter(X)Action Intervention (PIXI)

Who this might be right for
Fragile X SyndromeAngelman SyndromePrader-Willi Syndrome+11 more
RTI International 120
Not applicableLooking for participantsNCT06315777
What this trial is testing

GREM1, HAS2 and PTGS2 Gene Expression Following the in Vitro Maturation (IVM)

Who this might be right for
Increased Oocyte Deathin Vitro MaturationGREM1 Gene Mutation+1 more
National University of Malaysia 30
Not applicableNot Yet RecruitingNCT06044792
What this trial is testing

The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH

Who this might be right for
HivAIDSCD4 Deficiency+3 more
Medical University of Warsaw 50
Testing effectiveness (Phase 2)Study completedNCT03650452
What this trial is testing

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

Who this might be right for
EpilepsyDravet SyndromeLennox-Gastaut Syndrome
Takeda 141
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07079696
What this trial is testing

Investigating the Therapeutic Efficacy of All-trans Retinoic Acid in Autism Spectrum Disorder Patients With 15q11-13 Duplication Syndrome

Who this might be right for
Dup15q SyndromeAutism Spectrum DisorderTherapy+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 90